[1] 邢晟,王淑华,胡文红,等.益生菌制剂开发及相关质量标准构建策略[J].中国新药杂志,2021,30(9):773
XING S,WANG SH,HU WH,et al.Strategy for the development of probiotic preparations and the construction of related quality standards[J].Chin J New Drugs,2021,30(9):773
[2] 郑跃杰,黄志华,刘作义,等.微生态制剂儿科应用专家共识(2010年10月)[J].中国实用儿科杂志,2011,26(1):20
ZHENG YJ,HUAN ZH,LIU ZY,et al.Expert consensus on pediatric application of microecological preparations(October 2010)[J].Chin J Pract Pediatr,2011,26(1):20
[3] 苏梦缘,伍新叶,朱曦,等.微生态制剂活菌的计数方法分析[J].中南农业科技,2022,43(3):139
SU MY,WU XY,ZHU X,et al.Analysis of counting methods for active microorganisms in microecological preparations[J].South Cent Agric Sci Technol,2022,43(3):139
[4] 谢九艳,赵婷,高逸,等.发酵乳中乳酸菌的选择性计数及分离鉴定[J].食品与发酵工业,2022,48(10):35
XIE JY,ZHAO T,GAO Y,et al.Selective counting and isolation identification of lactic acid bacteria in fermented milk[J].Food Ferment Ind,2022,48(10):35
[5] 中国食品科学技术学会益生菌分会.益生菌“量效关系”的科学综述[J].中国食品学报,2022,22(7):443
Probiotics Society of the Chinese Institute of Food Science and Technology.A scientific review of the “dose-response relationship” of probiotics[J].J Chin Inst Food Sci Technol,2022,22(7):443
[6] 胡朝晖,朱庆义,刘本荣,等.军团菌选择性分离培养基及其实用性比较研究[J].国际检验医学杂志,2006,27(3):209
HU CH,ZHU QY,LIU BR,et al.Comparative study on selective isolation culture medium for Legionella and its practicality[J].Int J Lab Med,2006,27(3):209
[7] 马筱玲. 2015年CLSI药敏试验执行标准主要更新[G]//中华医学会,中华医学会微生物学与免疫学分会.中华医学会第十二次全国临床微生物学术年会暨第十一次全球华人临床微生物学与感染症学术年会论文汇编,兰州. 2015:29
MA XL.Major Updates to the 2015 CLSI Antimicrobial Susceptibility Testing Standards[G]// Chinese Medical Association,Society of Microbiology and Immunology,CMA.Compilation of Papers from the 12th National Annual Conference on Clinical Microbiology & the 11th Global Chinese Conference on Clinical Microbiology and Infectious Diseases,Lanzhou.2015:29
[8] REPORT E.Scientific opinion on the development of a risk ranking toolbox for the EFSA BIOHAZ Panel[J].EFSA J,2015,13(1).doi:10.2903/j.efsa.2015.3939
[9] 刘玉庆,李璐璐,骆延波,等.EUCAST欧盟药敏试验标准[J].中国质量与标准导报,2016,19(5):60
LIU YQ,LI LL,LUO YB,et al.EUCAST EU drug susceptibility testing standards[J].China Qual Stand Rev,2016,19(5):60
[10] 郭世富. 抗菌药物敏感性体外检测系统质量控制标准[J].国外医药抗生素分册,2019,40(1):42
GUO SF.Quality control standards for antimicrobial susceptibility in vitro detection system[J].World Notes Antibiot,2019,40(1):42
[11] 李璐璐,骆延波,胡明,等.抗生素药敏试验国际标准比较[J].家禽科学,2014,2014(9):20
LI LL,LUO YB,HU M,et al.Comparison of international standards for antibiotic susceptibility testing[J].China Poul Sci,2014,2014(9):20
[12] ZHAO Y,YU L,TIAN F,et al.An optimized culture medium to isolate Lactobacillus fermentum strains from the human intestinal tract[J].Food Funct,2021,12(15):6740
[13] HU X,ZHAO Y,HAN PL,et al,Novel clinical mngs-based machine learning model for rapid antimicrobial susceptibility testing of Acinetobacter baumannii[J].J Clin Microbiol,2023,61(5):e0180522
[14] AUSTIN I,ROMNEY H.The genotype—phenotype conundrum for antimicrobial susceptibility testing[J].Clin Chem,2023,69(4):316
[15] AGYEMAN WY,BISHT A,GOPINATH A,et al.A systematic review of antibiotic resistance trends and treatment options for hospital-acquired multidrug-resistant infections[J].Cureus,2022,14(10):e29956
[16] 刘立明,陈坚.基因组规模代谢网络模型构建及其应用[J].生物工程学报,2010,26(9):1176
LIU LM,CHEN J.Construction and application of genomic scale metabolic network model[J].Chin J Biotechnol,2010,26(9):1176
[17] LUO R,LIU B,XIE Y,et al.SOAPdenovo2:an empirically improved memory-efficient short-read de novo assembler[J].Gigascience,2012,1(1):18
[18] OGATA H,GOTO S,SATO K,et al.KEGG:kyoto encyclopedia of genes and genomes[J].Nucleic Acids Res,1999,27(1):29
[19] CONSORTIUM GO.The Gene Ontology(GO)database and informatics resource[J].Nucleic Acids Res,2004,32(suppl_1):258
[20] TATUSOV RL,GALPERIN MY,NATALE DA,et al.The COG database:a tool for genome-scale analysis of protein functions and evolution[J].Nucleic Acids Res,2000,28(D1):D33
[21] CONSORTIUM UP.UniProt:a hub for protein information[J].Nucleic Acids Res,2015,43(D1):D204
[22] FINN RD,PENELOPE C,EBERHARDT RY,et al.The Pfam protein families database:towards a more sustainable future[J].Nucleic Acids Res,2016,44(D1):D279
[23] ALCOCK BP,RAPHENYA AR,LAU TTY,et al.CARD 2020:antibiotic resistome surveillance with the comprehensive antibiotic resistance database[J].Nucleic Acids Res,2020,48(D1):D517
[24] DRULA E,GARRON ML,DOGAN S,et al.The carbohydrate-active enzyme database:functions and literature[J].Nucleic Acids Res,2021,49(D1):D571
[25] LIU B,ZHENG D,ZHOU S,et al.VFDB 2022:a general classification scheme for bacterial virulence factors[J].Nucleic Acids Res,2022,50(D1):D912
[26] SUZEK BE,YUQI W,HONGZHAN H,et al.UniRef clusters:a comprehensive and scalable alternative for improving sequence similarity searches[J].Bioinformatics,2015,31(6):926
[27] HERNÁNDEZ-SALMERÓN EJ,MORENO-HAGELSIEB G.Progress in quickly finding orthologs as reciprocal best hits:comparing blast,last,diamond and MMseqs2[J].BMC Genomics,2020,21(1):741
[28] HUSON DH,BUCHFINK B.Fast and sensitive protein alignment using DIAMOND[J].Nat Methods,2015,12(1):59
[29] SPEER BS,SALYERS AA.Novel aerobic tetracycline resistance gene that chemically modifies tetracycline[J].J Bacteriol,1989,171(1):148
[30] YANG W,MOORE IF,KOTEVA KP,et al.TetX is a flavin-dependent monooxygenase conferring resistance to tetracycline antibiotics[J].J Biol Chem,2004,279(50):52346
[31] CROWE-MCAULIFFE C,MURINA V,TURNBULL KJ,et al.Structural basis for PoxtA-mediated resistance to phenicol and oxazolidinone antibiotics[J].Nat Commun,2022,13(1):1860
[32] CHUNYAN X,NANNAN W,DEXI L,et al.Recombination events that occur in a poxtA-carrying Enterococcus faecium during the conjugation process[J].J Antimicrob Chemother,2022,77(5):1228
[33] 崔兰卿,吕媛.介导利奈唑胺耐药的新基因poxtA研究进展[J].中国临床药理学杂志,2019,35(22):2915
CUI LQ,LYU Y.Research progress of novel linezolid resistance gene poxtA[J].Chin J Clin Pharmacol,2019,35(22):2915
[34] POIREL L,JAYOL A,NORDMANN P.Polymyxins:antibacterial activity,susceptibility testing,and resistance mechanisms encoded by plasmids or chromosomes[J].Clin Microbiol Rev,2017,30(2):557
[35] REYGAERT WC.An overview of the antimicrobial resistance mechanisms of bacteria[J].AIMS Microbiol,2018,4(3):482
[36] 李岩,王晶,张桂,等.2012-2014年辽宁省大连市某医院分离粪肠球菌耐药性及多位点序列分析[J].疾病监测,2018,33(5):391
LI Y,WANG J,ZHANG G,et al.Drug resistance and multi site sequence analysis of Enterococcus faecalis isolated from a hospital in Dalian,Liaoning Province from 2012 to 2014[J].Dis Surveil,2018,33(5):391
[37] LIU XM,ZHANG CQ,ZHAO YX,et al.Comparison of antibacterial activities and resistance mechanisms of omadacycline and tigecycline against Enterococcus faecium[J].J Antibiot(Tokyo),2022,75(8):463
[38] ZHANG H,WEI W,HUANG M,et al.Definition of a family of nonmobile colistin resistance(NMCR-1)determinants suggests aquatic reservoirs for MCR-4[J].Adv Sci(Weinh),2019,6(11).doi:10.1002/advs.201900038
[39] LIU YY,WANG Y,WALSH TR,et al.Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China:a microbiological and molecular biological study[J].Lancet Infect Dis,2016,16(2):161
[40] BOOLCHANDANI M,D';SOUZA AW,DANTAS G.Sequencing-based methods and resources to study antimicrobial resistance[J].Nat Rev Genet,2019,20(6):356
[41] HEBBRING S.Genomic and phenomic research in the 21st century.trends in genetics[J].Trends Genet,2019,35(1):29
[42] RUPPÉ E,D';HUMIÈRES C,ARMAND-LEFÈVRE L.Inferring antibiotic susceptibility from metagenomic data:dream or reality?[J].Clin Microbiol Infect,2022,28(9):1225
[43] 李平兰,潘伟好,吕艳妮,等.微生态制剂中常用乳酸菌对抗生素的药敏性研究[J].中国农业大学学报,2004,9(1):16
LI PL,PAN WH,LYU YN,et al.Study on the antimicrobial susceptibility of lactic acid bacteria commonly used in microecological preparations[J].J China Agric Univ,2004,9(1):16
[44] 李晓姝,殷瑞敏,毛丙永,等.副干酪乳杆菌的基因多样性及其抗生素耐受性分析[J].食品与发酵工业,2019,45(14):1
LI XS,YIN RM,MAO BY,et al.Gene diversity and antibiotic resistance analysis of Lactobacillus paracasei[J].Food Ferment Ind,2019,45(14):1
[45] 冯丹阳,孟晓丽,沈振,等.微生态活菌制品杂菌检查方法适用性研究及决策方法的建立[J].药物分析杂志,2024,44(8):1415
FENG DY,MENG XL,SHEN Z,et al.Study on the applicability of microbial inspection methods for microbial products and establishment of decision making methods[J].Chin J Pharm Anal,2024,44(8):1415
